These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28602840)

  • 1. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LCC
    Microb Pathog; 2017 Aug; 109():233-238. PubMed ID: 28602840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells.
    Goulart C; Darrieux M; Rodriguez D; Pimenta FC; Brandileone MC; de Andrade AL; Leite LC
    Vaccine; 2011 Feb; 29(8):1634-42. PubMed ID: 21211592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades.
    Darrieux M; Moreno AT; Ferreira DM; Pimenta FC; de Andrade ALSS; Lopes APY; Leite LCC; Miyaji EN
    J Med Microbiol; 2008 Mar; 57(Pt 3):273-278. PubMed ID: 18287288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.
    Miyaji EN; Ferreira DM; Lopes AP; Brandileone MC; Dias WO; Leite LC
    Infect Immun; 2002 Sep; 70(9):5086-90. PubMed ID: 12183557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
    Piao Z; Akeda Y; Takeuchi D; Ishii KJ; Ubukata K; Briles DE; Tomono K; Oishi K
    Vaccine; 2014 Sep; 32(43):5607-13. PubMed ID: 25132335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
    Moreno AT; Oliveira ML; Ferreira DM; Ho PL; Darrieux M; Leite LC; Ferreira JM; Pimenta FC; Andrade AL; Miyaji EN
    Clin Vaccine Immunol; 2010 Mar; 17(3):439-46. PubMed ID: 20089795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
    Xin W; Li Y; Mo H; Roland KL; Curtiss R
    Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
    Miyaji EN; Dias WO; Tanizaki MM; Leite LC
    FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
    Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
    J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
    Oliveira ML; Miyaji EN; Ferreira DM; Moreno AT; Ferreira PC; Lima FA; Santos FL; Sakauchi MA; Takata CS; Higashi HG; Raw I; Kubrusly FS; Ho PL
    PLoS One; 2010 May; 5(5):e10863. PubMed ID: 20523738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC; Bosarge JR; Quin LR; McDaniel LS
    Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.
    Vadesilho CF; Ferreira DM; Gordon SB; Briles DE; Moreno AT; Oliveira ML; Ho PL; Miyaji EN
    Clin Vaccine Immunol; 2014 Jul; 21(7):940-8. PubMed ID: 24807052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
    Genschmer KR; Accavitti-Loper MA; Briles DE
    Vaccine; 2013 Dec; 32(1):39-47. PubMed ID: 24211169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
    Lu J; Guo J; Wang D; Yu J; Gu T; Jiang C; Kong W; Wu Y
    Hum Vaccin Immunother; 2019; 15(2):371-380. PubMed ID: 30235046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.